Full metadata record
DC FieldValueLanguage
dc.contributor.authorKo, Mei Lanen_US
dc.contributor.authorWei, Kai Linen_US
dc.contributor.authorHo, Yi-Jungen_US
dc.contributor.authorPeng, Pai Hueien_US
dc.contributor.authorLu, Henry Horng Shingen_US
dc.date.accessioned2019-04-02T06:01:05Z-
dc.date.available2019-04-02T06:01:05Z-
dc.date.issued2019-01-01en_US
dc.identifier.issn0929-6646en_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.jfma.2018.07.011en_US
dc.identifier.urihttp://hdl.handle.net/11536/148707-
dc.description.abstractBackground/Purpose: To investigate the knowledge and learning ability of glaucoma patients regarding their anti-glaucoma topical medications. Methods: Patients on regular follow-up at the Glaucoma Clinic at Hsin-Chu General Hospital were recruited. After detailed ocular examinations, the participants were asked to recall and identify their glaucoma eye drops. The same test was repeated 3 months later. The results of both tests, the learning ability of patients regarding their glaucoma drugs, and the relationship between learning ability and demographic variables were evaluated. Results: Two hundred eighty-seven glaucoma patients participated in this study. Of the study population, 25.8% and 57.1% could recall their topical mediation at the first and second tests, whereas 72.1% and 88.5% could identify their prescribed eye drops at the first and second tests, respectively. Approximately 34% of the participants showed improved knowledge at the repeat test, whereas 40% of the participants showed no improvement. Participants with a better learning ability were more likely to be younger, with a higher level of education, and with less visual field impairment. Conclusion: The knowledge of glaucoma patients regarding their prescribed medication was deficient in Taiwan. Physician effort could improve knowledge on the prescribed drugs. Patient-centered education should be considered, targeting elderly individuals, illiterate individuals, and those with loss of visual function to increase compliance with glaucoma medication. Copyright (C) 2018, Formosan Medical Association. Published by Elsevier Taiwan LLC.en_US
dc.language.isoen_USen_US
dc.subjectGlaucoma drugsen_US
dc.subjectIdentificationen_US
dc.subjectKnowledgeen_US
dc.subjectRecallingen_US
dc.titleKnowledge of medications among patients with glaucoma in Taiwanen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.jfma.2018.07.011en_US
dc.identifier.journalJOURNAL OF THE FORMOSAN MEDICAL ASSOCIATIONen_US
dc.citation.volume118en_US
dc.citation.spage457en_US
dc.citation.epage462en_US
dc.contributor.department分子醫學與生物工程研究所zh_TW
dc.contributor.departmentInstitute of Molecular Medicine and Bioengineeringen_US
dc.identifier.wosnumberWOS:000455476100011en_US
dc.citation.woscount0en_US
Appears in Collections:Articles


Files in This Item:

  1. 12fd1a32a628ec1ae19ce9bfcfb3e5a9.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.